Skip to content
Home/GPs/BID Equity
BID Equity

BID Equity

Hamburg, Germany·Founded 2016··bidequity.de

BID Equity is a Hamburg-based private equity firm founded in 2016 by three former BCG consultants that invests exclusively in European B2B software companies, building market-leading platforms through a buy-and-build strategy with a focus on the DACH region.

AUM
€800M
Funds
4
vintages 2016–2025
Portfolio
12
Exits
6
SectorsSoftware

Key facts

HQHamburg, Germany
Founded2016
Employees30+

Recent exits

Nextron
Nextron
Cybersecurity2026 · 3yr hold
everii
everii
SaaS2025 · 3yr hold
JustRelate
JustRelate
SaaS2025 · 5yr hold
eSight Energy
Software2021 · 3yr hold

Coverage notes

4 funds tracked, 18 portfolio companies (12 active · 6 realized). Verified weekly from public filings and deal announcements.

Sector breakdown

18 companies
SaaS
5 · 28%
HealthTech
5 · 28%
Software
4 · 22%
InsurTech
1 · 6%
AdTech
1 · 6%
Cybersecurity
1 · 6%
PropTech
1 · 6%

Funds & portfolio

Every fund BID Equity has raised, with its portfolio companies. Hand-checked from public filings.

4 funds
BID Equity Continuation Fund IBuyout
2025 · 1yr€300M2 active

Unrealized

2 held
everii
everiiActive
SaaSGermany· Entry 2025
JustRelate
JustRelateActive
SaaSGermany· Entry 2025
BID Equity Fund IIIBuyout
2023 · 3yr€310M5 active · 1 realized

Unrealized

5 held
Crisalix
CrisalixActive
HealthTechSwitzerland· Entry 2024
InsurgoActive
InsurTechGermany· Entry 2025
AdTechGermany· Entry 2026
REALVIEW
RealviewActive
PropTechSwitzerland· Entry 2024
TinyMDM
TinyMDMActive
SoftwareFrance· Entry 2025

Realized

1 exit
Nextron
NextronExited 2026
CybersecurityGermany· Entry 2023
Secondaryto
BID Equity Fund IIBuyoutHarvesting
2019 · 7yr€125M5 active · 2 realized

Unrealized

5 held
AB CUBE
AB CubeActive
HealthTechFrance· Entry 2022
EvidentIQ
EvidentIQActive
HealthTechGermany· Entry 2019
FarMedvisie
FarMedvisieActive
HealthTechNetherlands· Entry 2022
HQLabsActive
SoftwareGermany· Entry 2022
MegaCAD
MegaCADActive
SoftwareGermany· Entry 2023

Realized

2 exits
everii
everiiExited 2025
SaaSGermany· Entry 2022
Continuation Vehicleto
JustRelate
JustRelateExited 2025
SaaSGermany· Entry 2020
Continuation Vehicleto
BID Equity Investment I FundBuyoutRealized
2016 · 10yr0 active · 3 realized

Realized

3 exits
eSight EnergyExited 2021
SoftwareUK· Entry 2018
Trade Saleto
Midoco
MidocoExited 2019
SaaSGermany· Entry 2016
Secondaryto
myneva
mynevaExited 2021
HealthTechGermany· Entry 2017
Secondaryto
Track BID Equity

Saved GPs appear in your watchlist, one click from your workspace.

About BID Equity

BID Equity is an alternative investment platform with capital deployed across 4 active fund vehicles, headquartered in Frankfurt. The firm deploys capital across European mid and small-cap businesses spanning TMT, healthcare, industrials and software.

Investment thesis

The platform combines complementary investment strategies, deploying capital across TMT, healthcare, industrials and software businesses in Germany and the DACH region. Multi-strategy capital deployment enables flexibility across the business lifecycle, with the partnership culture supporting management teams through growth, transmission and selective M&A across multiple fund vintages and asset classes.

Recent activity

Recent realised exits include JustRelate Group (TMT, 2025), everii Group (TMT, 2025), myneva Group (healthcare, 2021) and Abionik Group (industrials, 2021). The platform tracks 4 fund vehicles, 14 active portfolio companies and 6 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.

Get the full picture on BID Equity.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Save this GP to your watchlist
Saved searches that re-run your sourcing filters in one click
Geography breakdown across 5 geographies
Exit buyers and MOIC on every realized deal (Pro)
Export, compare GPs side by side (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Last updated August 2026 · Sourced from public filings · Report an issue